XML 50 R35.htm IDEA: XBRL DOCUMENT v3.26.1
Share Based Payment (Tables)
12 Months Ended
Dec. 31, 2025
Share Based Payment [Abstract]  
Schedule of Fair Value of the Options Granted

The following table lists the inputs used for calculation of fair value of the options and restricted shares granted to employees and directors for the years ended December 31, 2025, 2024 and 2023:

 

   2025   2024   2023 
Expected volatility   92.06% - 96.40%   93.72%   91.80% - 93.51%
Discount for lack of marketability   23.65%   -    - 
Exercise price   0.93    1.27    0.96 - 1.99 
Share price   0.93 – 1.22    1.27    0.96 - 1.99 
Risk-free interest rate   4.38%   4.61%   3.24% - 4.35% 
Dividend yield   0    0    0 
Expected life (years)   2 – 2.8    2 – 2.8    2 – 2.8 

 

The following table lists the inputs used for calculation of fair value of the options granted to consultants for the years ended December 31, 2025, 2024 and 2023:

 

   2025   2024   2023 
Expected volatility   102.22%   -    100.540%
Exercise price   0.93    -    1.82 
Share price   0.93    -    1.82 
Risk-free interest rate   4.38%   -    3.64%
Dividend yield   0    -    0 
Expected life (years)   10    -    10 
Schedule of Share Option Activity

The following table summarizes the share option activity for employees, directors, and non-employees for the annual periods ended on December 31, 2025:

 

   Number of   Weighted
Average
   Weighted
average
remaining
   Intrinsic
value
 
   Share
Options
   Exercise
Price
   contractual
life (years)
   U.S. dollars
in thousands
 
Options outstanding at January 1, 2025   1,069,128   $2.30    6.7   $- 
Granted   118,000   $0.93    10   $- 
Exercised   (23,000)  $0.95    -   $- 
Forfeited   (73,000)  $2.78    -   $- 
Options outstanding at December 31, 2025   1,091,128   $2.15    6.4   $- 
Exercisable at December 31, 2025   963,128   $2.31    6.1   $- 

 

(*) less than $1 thousand
Schedule of Restricted Stock Unit (RSU’s) Activity

The following table summarizes the RSUs restricted stock award activity for the annual periods ended on December 31, 2025:

 

       Weighted
average
grant date
fair value
 
   Number of
RSUs
   U.S. dollars
in thousands
 
Outstanding at January 1, 2024   317,000   $249 
Granted   208,000    224 
Issued   (325,000)   640 
Outstanding at December 31, 2024   200,000   $236 
           
Granted   4,228,705   $3,824 
Issued   (4,378,705)   3,918 
Outstanding at December 31, 2025   50,000    142 
Schedule of Share-Based Expense Recognized in the Statements of Operation

The share-based expense recognized in the statements of operations were as follows:

 

   For the year ended December 31, 
   2025   2024   2023 
   U.S. dollars in thousands 
Share-based compensation expense - Research and development  $1,262   $193   $575 
Share-based compensation expense - General and administrative   878    364    962 
   $2,140   $557   $1,537